|
BMS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.385300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.075900E-03 |
| Normal-vs-Stage2 |
2.540000E-02 |
| Normal-vs-Stage3 |
7.632500E-04 |
| Normal-vs-Stage4 |
4.34340000000644E-05 |
| Stage1-vs-Stage2 |
6.041600E-01 |
| Stage1-vs-Stage3 |
5.087600E-01 |
| Stage1-vs-Stage4 |
1.033160E-01 |
| Stage2-vs-Stage3 |
3.378600E-01 |
| Stage2-vs-Stage4 |
8.262400E-02 |
| Stage3-vs-Stage4 |
4.088800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.394000E-04 |
| Normal-vs-AfricanAmerican |
2.578600E-01 |
| Normal-vs-Asian |
8.137700E-03 |
| Caucasian-vs-AfricanAmerican |
1.840770E-01 |
| Caucasian-vs-Asian |
7.392800E-01 |
| AfricanAmerican-vs-Asian |
2.715800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.436500E-04 |
| Normal-vs-Female |
8.159500E-04 |
| Male-vs-Female |
3.558200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.187100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.642700E-04 |
| Normal-vs-Age(61-80Yrs) |
5.676100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.741040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.747800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.021400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.525800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.910400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.932000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.156200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.546240E-01 |
| Classical-VS-Follicular |
9.687800E-02 |
| Classical-VS-Other |
2.881900E-02 |
| Classical-VS-Normal |
3.501700E-03 |
| Tall-VS-Follicular |
9.936800E-01 |
| Tall-VS-Other |
2.415200E-01 |
| Tall-VS-Normal |
3.276600E-03 |
| Follicular-VS-Other |
3.110200E-01 |
| Follicular-VS-Normal |
6.613000E-04 |
| Other-VS-Normal |
2.040600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.848200E-04 |
| Normal-vs-N1 |
3.76460000000023E-05 |
| N0-vs-N1 |
1.396440E-01 |
|
|
